KRRO

Korro Bio (KRRO)

Korro Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KRRO

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/18	05:27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/06/18	05:22	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/06/13	06:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/06/13	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/06/13	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/06/05	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/05/31	05:01	GlobeNewswire Inc.	Korro to Participate in Upcoming June Investor and Scientific Conferences	NASDAQ:KRRO	Korro Bio Inc
2024/05/23	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KRRO	Korro Bio Inc
2024/05/23	05:37	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/05/21	03:30	GlobeNewswire Inc.	Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	09:22	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05:34	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05:20	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/05/15	05:01	GlobeNewswire Inc.	Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer	NASDAQ:KRRO	Korro Bio Inc
2024/04/18	21:30	GlobeNewswire Inc.	Korro Announces $70 Million Private Placement	NASDAQ:KRRO	Korro Bio Inc
2024/04/02	05:01	GlobeNewswire Inc.	Korro to Participate in Upcoming Investor Conferences	NASDAQ:KRRO	Korro Bio Inc
2024/03/27	05:01	GlobeNewswire Inc.	Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress	NASDAQ:KRRO	Korro Bio Inc
2024/02/27	22:00	GlobeNewswire Inc.	Korro to Present at the TD Cowen 44th Annual Health Care Conference	NASDAQ:KRRO	Korro Bio Inc
2024/01/18	22:00	GlobeNewswire Inc.	Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio	NASDAQ:KRRO	Korro Bio Inc
2024/01/09	23:02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2024/01/09	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRRO	Korro Bio Inc
2024/01/04	22:00	GlobeNewswire Inc.	Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:KRRO	Korro Bio Inc
2023/12/26	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:KRRO	Korro Bio Inc
2023/12/23	06:31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:KRRO	Korro Bio Inc
2023/12/21	06:44	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:KRRO	Korro Bio Inc
2023/12/07	22:00	GlobeNewswire Inc.	Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)	NASDAQ:KRRO	Korro Bio Inc
2023/12/02	06:07	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:KRRO	Korro Bio Inc